P15121 (ALDR_HUMAN) Homo sapiens (Human)

Aldo-keto reductase family 1 member B1 UniProtKBInterProSTRINGInteractive Modelling

316 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: A0A024R7A8

Available Structures

156 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
FIDARESTAT BOUND TO HUMAN ALDOSE REDUCTASEhomo-2-merNAP;FID;2-316
Assess
Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,6-difluorobenzyl)carbamoyl]-5…monomerNAP;4O8;1-316
Assess
Crystal structure of Aldose Reductase complexed with 2S4R (Stereoisomer of Fidarestat, 2S4S) at 0.7…monomerNAP;CIT;FIS;1-316
Assess
Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(2,6-difluoro-4-iodobenzyl)carb…monomerNAP;4O9;1-316
Assess
Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(2-fluoro-4-iodobenzyl)carbamoy…monomerNAP;M15;1-316
Assess
Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,3,5,6-tetrafluorobenzyl)carba…monomerNAP;1WX;1-316
Assess
Human aldose reductase in complex with NADP and citrate at 0.82 angstrommonomerNAP;FLC;1-316
Assess
Crystal structure of human AR complexed with NADP+ and {2-[(4-bromobenzyl)carbamoyl]-5-chlorophenox…monomerNAP;W8X;1-316
Assess
Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat a…monomerCL;NDP;LDT;FID;CIT;1-316
Assess
Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(4-iodobenzyl)carbamoyl]phenoxy…monomerNAP;1WW;1-316
Assess
Crystal structure of human Aldose Reductase complexed with NADP+ and JF0064monomerNAP;64I;1-316
Assess
Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat a…monomerCL;NDP;LDT;FID;CIT;1-316
Assess
AKR1B1 at 0.03 MGy radiation dose.monomerNAP;CIT;1-316
Assess
Crystal structure of human Aldose Reductase complexed with NADP and FidarestatmonomerCL;NAP;FID;1-316
Assess
human Aldose Reductase in complex with SAR25monomerNAP;CIT;M0K;1-316
Assess
Crystal structure of human AKR1B1 complexed with NADP+ and compound 37monomerNAP;AV5;1-316
Assess
Human Aldose Reductase mutant T113V complexed with IDD388monomerNAP;388;CIT;BR;1-316
Assess
Human Aldose Reductase Mutant L300/301A in Complex with a Ligand with an IDD Structure (3-({[2-(car…monomer4G7;CIT;NAP;1-316
Assess
Human Aldose Reductase Mutant L300A in Complex with a Ligand with an IDD Structure (3-({[2-(carboxy…monomerCIT;4G7;NAP;1-316
Assess
Crystal structure of human AKR1B1 complexed with NADP+ and compound 41monomerNAP;AVT;1-316
Assess
Crystal structure of human AKR1B1 complexed with NADP+ and compound 39monomerNAP;AW8;1-316
Assess
Human Aldose Reductase complexed with Schl12221 ({2-[5-(3-NITROPHENYL)FURAN-2-YL]PHENYL}ACETIC ACID…monomerNAP;2WB;1-316
Assess
AKR1B1 at 0.75 MGy radiation dose.monomerNAP;CIT;1-316
Assess
Human Aldose Reductase Mutant L301A in Complex with a Ligand with an IDD Structure ({5-fluoro-2-[(3…monomer30L;CIT;NAP;1-316
Assess
Human Aldose Reductase Mutant L300A in Complex with a Ligand with an IDD Structure ({5-fluoro-2-[(3…monomerNAP;30L;CIT;1-316
Assess
Human Aldose Reductase Mutant L300/301A in Complex with a Ligand with an IDD Structure ({5-fluoro-2…monomer30L;CIT;NAP;1-316
Assess
Human Aldose Reductase complexed with a ligand with an IDD structure ({5-fluoro-2-[(3-nitrobenzyl)c…monomerNAP;30L;CIT;1-316
Assess
Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effe…monomerNDP;LDT;CIT;1-316
Assess
Aldose Reductase Mutant Leu 300 Pro complexed with FidarestatmonomerCL;NAP;FID;CIT;1-316
Assess
Crystal structure of human Aldose Reductase complexed with NADP+ and JF0048monomerNAP;48I;1-316
Assess
The crystallographic structure of Aldose Reductase IDD393 complex confirms Leu300 as a specificity …monomerNAP;393;1-316
Assess
Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effe…monomerNDP;LDT;CIT;1-316
Assess
Human Aldose Reductase Mutant L301A in Complex with a Ligand with an IDD Structure (3-({[2-(carboxy…monomer4G7;CIT;NAP;1-316
Assess
Human Aldose Reductase complexed with Schl12134 (3-[5-(3-nitrophenyl)-2-thienyl]propanoic acid) at …monomerNAP;53N;1-316
Assess
AKR1B1 at 1.65 MGy radiation dose.monomerNAP;CIT;1-316
Assess
Human aldose reductase in complex with NADP+ and the inhibitor lidorestat at 1.04 angstrommonomerNDP;3NA;1-316
Assess
Crystal structure of human aldose reductase complexed with NADP and IDD552monomerNAP;ID5;1-316
Assess
Human Aldose Reductase complexed with a ligand with an IDD structure (2-[2-(1,3-benzothiazol-2-ylme…monomerNAP;37V;1-316
Assess
Human Aldose Reductase complexed with a ligand with an IDD structure (2) at 1.07 A.monomerNAP;4G7;1-316
Assess
Human Aldose Reductase mutant T113V in complex with ZopolrestatmonomerNAP;ZST;1-316
Assess
AKR1B1 at 2.55 MGy radiation dose.monomerNAP;CIT;1-316
Assess
Crystal structure of human Aldose Reductase complexed with NADP and MinalrestatmonomerBFI;NAP;1-316
Assess
Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effe…monomerNDP;LDT;CIT;1-316
Assess
Structure of Human Aldose Reductase Mutant L301A with a Citrate Molecule Bound in the Anion Binding…monomerCIT;NAP;1-316
Assess
Human Aldose Reductase complexed with a ligand with an IDD structure (2-[5-fluoro-2-(prop-2-ynylcar…monomer2WQ;CIT;NAP;1-316
Assess
Human Aldose Reductase mutant T113V in complex with IDD393 crystallized in spacegroup P1monomerNAP;393;1-316
Assess
Human Aldose Reductase complexed with a ligand with an IDD structure (2-(2-carbamoyl-5-fluoro-pheno…monomerNAP;2WR;1-316
Assess
Human Aldose Reductase in complex with ALR43monomerCIT;NAP;NXQ;1-316
Assess
Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effe…monomerNDP;LDT;CIT;1-316
Assess
Human Aldose Reductase complexed with a ligand with a new scaffold at 1.26 AmonomerNAP;3E2;1-316
Assess
Human aldose reductase in complex with a nitrile-containing IDD inhibitormonomerNAP;3T4;CIT;1-316
Assess
Structure of Human Aldose Reductase Mutant L300A with a Citrate Molecule Bound in the Anion Binding…monomerCIT;NAP;1-316
Assess
Crystal structure of Aldose Reductase complexed with 2S4R (Stereoisomer of Fidarestat, 2S4S)monomerNAP;CIT;FIS;1-316
Assess
Human aldose reductase mutant T113V complexed with IDD393monomerNAP;393;1-316
Assess
Crystal structure of Aldose Reductase complexed with 2R4S (Stereoisomer of Fidarestat, 2S4S)monomerNAP;FIR;1-316
Assess
Crystal structure of Aldose Reductase with citrates bound in the active sitemonomerNAP;CIT;1-316
Assess
Human Aldose Reductase complexed with novel Sulfonyl-pyridazinone InhibitormonomerNAP;62P;1-316
Assess
Aldose reductase complexed with nitrophenyl-oxadiazol type inhibitor at 1.43 AmonomerNAP;BTO;1-316
Assess
Human Aldose Reductase complexed with four tolrestat molecules at 1.5 A resolution.monomerNAP;TOL;1-316
Assess
Human Aldose Reductase C298S mutant in Complex with NADP+ in Space Group P212121monomerNAP;SO4;1-316
Assess
Human Aldose Reductase in Complex with NADP+ and WY14643 in Space Group P212121monomerNAP;WY1;SO4;1-316
Assess
Novel Benzothiazepine Inhibitor in Complex with human Aldose ReductasemonomerNAP;DOY;1-316
Assess
Structure of Human Aldose Reductase Mutant L300/301A with a Citrate Molecule Bound in the Anion Bin…monomerCIT;NAP;1-316
Assess
HUMAN ALDOSE REDUCTASE COMPLEXED WITH IDD384 INHIBITORmonomerNAP;I84;1-316
Assess
Crystal Structure of Human Aldose Reductase Complexed with TolmetinmonomerNAP;TLT;1-316
Assess
Human aldose reductase complexed with IDD 740 inhibitormonomerNDP;Q74;1-316
Assess
Crystal structure of human aldose reductase complexed with NADP and IDD552 at ph 5monomerNAP;ID5;1-316
Assess
Crystal Structure of Human Aldose Reductase Complexed with SulindacmonomerNAP;SUZ;1-316
Assess
Aldose reductase complexed with a nitro compoundmonomerNAP;NTI; 23×DMF;1-316
Assess
Crystal Structure of Human Aldose Reductase Complexed with Sulindac SulfonemonomerNAP;SLO;1-316
Assess
Crystal Structure of Human Aldose Reductase complexed with Sulindac SulfidemonomerNAP;SFI;1-316
Assess
Crystal Structure Of Aldose Reductase (AKR1B1) Complexed With NADP+ And EpalrestatmonomerEPR;SO4;NAP;1-316
Assess
Aldose reductase complexed with glceraldehydemonomerNAP;3GR;0PY;1-316
Assess
Human Aldose Reductase in Complex with NADP+ in Space Group P212121monomerNAP;SO4;GOL;1-316
Assess
Crystal structure of human Aldose Reductase complexed with NADP+ and JF0049monomerNAP;F49;1-316
Assess
Human Aldose Reductase structuremonomerNAP;LDT;1-316
Assess
Complex of Aldose Reductase with inhibitor IDD 1219monomerNAP;2X9;2-316
Assess
Human Aldose Reductase complexed with novel Sulfonyl-pyridazinone InhibitormonomerNAP;62P;2-316
Assess
Aldose reductase in complex with NSAID-type inhibitor at 1.0 A resolutionmonomerNAP;PEG;PG5;CIT;SUZ;PG4;2-316
Assess
Human Aldose Reductase complexed with Schl7815 ((3-[3-(5-NITROFURAN-2-YL)PHENYL]PROPANOIC ACID)at 1…monomerNAP;2W9;2-316
Assess
Human Aldose Reductase complexed with Schl7802 at 1.06 AmonomerNAP;2W8;2-316
Assess
Human aldose reductase mutant T113C complexed with IDD594monomerNAP;LDT;CIT;BR;2-316
Assess
Human Aldose Reductase complexed with a ligand with an IDD structure ([2-(benzylcarbamoyl)-5-fluoro…monomerNAP;2YZ;2-316
Assess
Aldose Reductase in complex with novel biarylic inhibitormonomerNAP;53N;2-316
Assess
Human aldose reductase mutant L300P complexed with uracil-type inhibitor at 1.45 A.monomerNAP;47D;2-316
Assess
Human aldose reductase mutant L301M complexed with tolrestat.monomerNAP;TOL;2-316
Assess
Human Aldose reductase complexed with inhibitor zopolrestat at 1.48 A(1 day soaking).monomerNAP;ZST;2-316
Assess
Human aldose reductase mutant C303D complexed with fidarestat.monomerNAP;FID;2-316
Assess
Human aldose reductase complexed with nitrofuryl-oxadiazol inhibitor at 1.55 AmonomerNAP;LIT;2-316
Assess
Human Aldose Reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (2)monomerNAP;ITB;2-316
Assess
Human aldose reductase mutant C303D complexed with IDD393.monomerNAP;393;2-316
Assess
Human aldose reductase mutant L301M complexed with sorbinil.monomerNAP;SBI;2-316
Assess
Human aldose reductase mutant L300A complexed with zopolrestat at 1.55 A.monomerNAP;ZST;2-316
Assess
Human aldose reductase complexed with nitro-substituted IDD-type inhibitormonomerNAP;393;2-316
Assess
Human aldose reductase mutant V47I complexed with fidarestat.monomerNAP;FID;2-316
Assess
Human aldose reductase mutant L300A complexed with IDD393.monomerNAP;393;2-316
Assess
Human Aldose Reductase-zopolrestat complex obtained by cocrystallisation after one day (1day_cocrys…monomerNAP;ZST;2-316
Assess
Human aldose reductase mutant V47I complexed with zopolrestatmonomerNAP;ZST;2-316
Assess
Human Aldose Reductase complexed with inhibitor zopolrestat after six days soaking.monomerNAP;ZST;2-316
Assess
Crystal structure of human Aldose Reductase complexed with zopolrestat after 3 days soaking (3days_…monomerNAP;ZST;2-316
Assess
Human Aldose Reductase complexed with inhibitor zopolrestat after 3 days soaking (3days_soaked_2)monomerNAP;ZST;2-316
Assess
Human aldose reductase mutant F121P complexed with zopolrestat.monomerNAP;ZST;2-316
Assess
Human Aldose Reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (3)monomerNAP;ITA;2-316
Assess
Human Aldose Reductase-zopolrestat complex obtained by cocrystallisation (10days_cocryst)monomerNAP;ZST;2-316
Assess
Human aldose reductase double mutant S302R-C303D complexed with fidarestat.monomerNAP;FID;2-316
Assess
Human aldose reductase mutant S302R complexed with IDD 393.monomerNAP;393;2-316
Assess
AN UNLIKELY SUGAR SUBSTRATE SITE IN THE 1.65 ANGSTROMS STRUCTURE OF THE HUMAN ALDOSE REDUCTASE HOLO…monomerNAP;2-316
Assess
Human aldose reductase mutant F121P complexed with IDD393.monomerNAP;393;2-316
Assess
Human aldose reductase mutant S302R complexed with uracil-type inhibitor.monomerNAP;47D;2-316
Assess
Crystal Structure of Aldose Reductase complexed with Dichlorophenylacetic acidmonomerNAP;2CL;2-316
Assess
Human aldose reductase mutant C303D complexed with uracil-type inhibitor.monomerNAP;47D;2-316
Assess
Human aldose reductase mutant S302R complexed with zopolrestat.monomerNAP;ZST;2-316
Assess
AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITRAT…monomerCAC;NAP;2-316
Assess
TYROSINE-48 IS THE PROTON DONOR AND HISTIDINE-110 DIRECTS SUBSTRATE STEREOCHEMICAL SELECTIVITY IN T…monomerNAP;CIT;2-316
Assess
AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITRAT…monomerG6P;NAP;2-316
Assess
REFINED 1.8 ANGSTROMS STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE POTENT INHIBITOR ZOPOL…monomerNAP;ZST;2-316
Assess
Aldose reductase tertiary complex with NADPH and DEGmonomerNDP;TGG;2-316
Assess
Crystal Structure of Aldose Reductase complexed with 2-Hydroxyphenylacetic AcidmonomerNAP;OHP;2-316
Assess
Crystal Structure of Aldose Reductase complexed with Lipoic AcidmonomerNAP;LPA;2-316
Assess
Apo R268A human aldose reductasemonomer2-316
Assess
CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE INHIBITOR ZENARESTAT.monomerNAP;ZES;2-316
Assess
Human Aldose Reductase in complex with NADP+ and the inhibitor IDD594 at 0.66 AngstrommonomerNDP;LDT;CIT;1-314
Assess
Human aldose reductase in complex with NADP+ and the inhibitor IDD594 at temperature of 60KmonomerNDP;LDT;CIT;1-314
Assess
Human aldose reductase in complex with NADP+ and the inhibitor IDD594 at temperature of 15KmonomerNDP;LDT;CIT;1-314
Assess
Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat a…monomerCL;NDP;LDT;FID;CIT;1-314
Assess
Crystal structure of human AR complexed with NADP+ and AK198monomerNAP;I98;1-314
Assess
Human Aldose Reductase mutant T113C in complex with IDD388monomerNAP;388;BR;CIT;1-314
Assess
Human Aldose Reductase complexed with Schl7764 at 1.12 Amonomer2HZ;NAP;3-316
Assess
AKR1B1 at 3.45 MGy radiation dose.monomerNAP;CIT;1-314
Assess
Human Aldose Reductase complexed with a ligand with an IDD structure at 1.20 A (1)monomer3UH;NAP;3-316
Assess
Human Aldose Reductase mutant T113S complexed with ZopolrestatmonomerNAP;ZST;3-316
Assess
Human aldose reductase with uracil-type inhibitor at 1.42A.monomerNAP;47D;3-316
Assess
Human aldose reductase mutant L300P complexed with zopolrestat.monomerNAP;ZST;3-316
Assess
Human Aldose Reductase complexed with inhibitor zopolrestat after three days soaking (3days_soaked_…monomerNAP;ZST;3-316
Assess
Human Aldose Reductase complexed with zopolrestat after 6 days soaking(6days_soaked_2)monomerNAP;ZST;3-316
Assess
Human Aldose Reductase mutant T113A complexed with ZopolrestatmonomerNAP;ZST;3-316
Assess
AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITRAT…monomerNAP;CIT;3-316
Assess
ALRESTATIN BOUND TO C298A/W219Y MUTANT HUMAN ALDOSE REDUCTASEmonomerNAP;ALR;3-316
Assess
Crystal Structure of Aldose Reductase complexed with Phenylacetic AcidmonomerNAP;PAC;3-316
Assess
Crystal Structure of Aldose Reductase complexed with Hexanoic AcidmonomerNAP;6NA;3-316
Assess
Crystal Structure of C298A W219Y Aldose Reductase complexed with Dichlorophenylacetic acidmonomerNAP;2CL;3-316
Assess
Crystal Structure of C298A W219Y Aldose Reductase complexed with Phenylacetic AcidmonomerNAP;PAC;3-316
Assess
THE CRYSTAL STRUCTURE OF THE ALDOSE REDUCTASE NADPH BINARY COMPLEXmonomerNDP;3-316
Assess
CITRATE BOUND, C298A/W219Y MUTANT HUMAN ALDOSE REDUCTASEmonomerNAP;CIT;3-316
Assess
Perdeuterated alr2 in complex with idd594monomerNDP;LDT;CIT;1-313
Assess
Human aldose reductase mutant T113V complexed with IDD594monomerNAP;LDT;CIT;1-313
Assess
Human aldose reductase mutant T113S complexed with IDD388monomerNAP;388;BR;CIT;1-313
Assess
Bond breakage and relocation of a covalently bound bromine of IDD594 in a complex with hAR T113A mu…monomerNAP;LDT;BR;CIT;2-314
Assess
Human Aldose Reductase in complex with ALR25monomerCIT;NXK;NAP;1-313
Assess
Human aldose reductase complexed with tolrestat at 1.08 A resolution.monomerNAP;TOL;1-313
Assess
Human Aldose Reductase mutant T113A complexed with IDD 594monomerNAP;LDT;CIT;BR;1-313
Assess
Bond breakage and relocation of a covalently bound bromine of IDD594 in a complex with hAR T113A mu…monomerNAP;LDT;BR;CIT;2-313
Assess
Human aldose reductase double mutant S302R-C303D complexed with zopolrestat.monomerNAP;ZST;2-313
Assess
Human aldose reductase mutant T113S complexed with IDD594monomerNAP;LDT;CIT;BR;3-313
Assess
Human aldose reductase mutant T113A complexed with IDD388monomerNAP;388;BR;3-313
Assess
Human aldose reductase complexed with halogenated IDD-type inhibitormonomerNAP;388;2-312
Assess

1 Homology model

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomerNAP;I84;0.891el3.1.A1-316
100.00
Assess

Alignments